More than Tested, Cured - Overcoming Barriers to HCV Care

Share this

Upcoming Events

Final More than Tested Project webinar coming in February 2018. Check back here for more details.


Recent Events

Meaningful Engagement of Participants in Hepatitis C Work Webinar

Tuesday, November 14, 2017

This webinar provided an update on the "More than Tested, Cured" project that addresses barriers to hepatitis C care faced by individuals who use drugs. The webinar included findings from interviews with participants and healthcare providers and suggested messaging to improve access to hepatitis C care. In addition, each partner discussed their methods for integrating participants into their work. These methods included increasing participant knowledge, training participants as educational leaders, and involving participants throughout the research process. After the presentation, there was time for questions and discussion.

Click here for the slides. Click here for the recording. (Click the link and then enter name and email address to view the webinar)

Click here for Urban Survivor's Union's social marketing materials.


World Hepatitis Summit Poster

The More than Tested, Cured Project had a poster presentation at the 2017 World Hepatitis Summit. Click here to view.


INHSU Conference Workshop

On September 8, 2017, the More than Tested, Cured project team hosted a workshop at the 6th international Symposium on Hepatitis Care in Substance Users in Jersey City, New Jersey.

Click here for the slides.

Click here for NVHR's handout.

Click here for People's Harm Reduction Alliance's handout.

Click here for Atlanta Harm Reduction Coalition's handout.

Project Update Webinar

On June 15, 2017, NVHR hosted a webinar that provided an update about the "More than Tested, Cured" project that addresses barriers to hepatitis C care faced by individuals who use drugs. In addition to a project update, there was time for Q&A and discussion.

The Atlanta Harm Reduction Coalition shared its findings from conversations with providers who treat active drug users. The People's Harm Reduction Alliance discussed its interviews with people who use drugs and their barriers to care. The Urban Survivor’s Union talked about its focus group data from people who use drugs, including specific focus groups with women and stimulant users.  

Click here for the slides. Click here for the recording. (Click the link and then enter name and email address to view the webinar)

Program Overview

The National Viral Hepatitis Roundtable (NVHR) has partnered with the Urban Survivor's Union (USU), the People’s Harm Reduction Alliance (PHRA), and the Atlanta Harm Reduction Coalition (AHRC) for a one year project aimed at addressing three of the most significant challenges associated with diagnosing hepatitis C (HCV) in individuals who use drugs and identifying best practices to assist those individuals in overcoming personal and systemic barriers to care. This project develops novel ways to engage individuals who use drugs while aiming to establish long-term, sustainable partnerships with public health stakeholders in an effort to introduce new paradigms of holistic care. Stigma and misconceptions held by patients as well as medical providers serve as significant barriers to identifying, treating, and curing hepatitis C among people who use drugs. The findings of this project will be disseminated nationally, and strategies can be refined and adapted in agencies across the country.


Program Objectives

This project addresses barriers at three points along the hepatitis C (HCV) care cascade:

1) Patient education – We will develop HCV education materials that are created by and for people who use drugs which include one video and four print companion pieces by end of one year grant.

2) Primary care referral to treatment - We will develop training and educational materials for primary care providers, including at least two pamphlets, two PowerPoint presentations, and one compilation of research articles and a report summarizing qualitative patient and provider experiences by end of one year grant.

3) Specialty care provision of treatment - We will develop at least two presentations and two packets of educational materials to address the misconceptions, stigma, and other reasons for refusal of specialty providers to treat drug users.


An Open Community Call to Discuss the Barriers to Hepatitis C Care for People Who Use Drugs

This call was the first public activity of this project and was held on March 6, 2017 and involved over 100 participants. The discussion focused on challenges that community organizations face in accessing hepatitis C prevention, care, and treatment services for people who use drugs. Common concerns included insurance coverage inequities, stigma among providers, and provider resistance to treat due to concerns about reinfection. Some solutions that were discussed included provider education programs (mostly intended to reduce stigma), patient education programs (that involve peer educators) and working with community partners to improve access to care for people who use drugs.

Click here for the call notes



Hep C & You – A Users Guide to the Latest Information - from Australian Injecting & Illicit Drug Users League

HCV Education Presentation for Drug Users – Please contact Bekeela Davila for the presentation

HCV Infographic - Courtesy of People's Harm Reduction Alliance - groups are welcome to
adapt these infographics based on local resources as this version is for Seattle, but we
ask that they acknowledge that it was adapted from PHRA

HCV Infographic 2 - Courtesy of People's Harm Reduction Alliance

State HCV Incidence and Policies Related to HCV Preventive and Treatment Services for Persons Who Inject Drugs — United States, 2015–2016

NYC Hep C Peer Navigation Program

HCV Treatment in People Who Inject Drugs Co-located within A Needle Syringe Program

The Increasing Role of Methadone Clinics for HCV Treatment, Education

Can methadone clinics also fight hepatitis C?

Onsite Treatment of HCV Infection with Direct Acting Antivirals within an Opioid Treatment Program